BioCardia to present CardiAMP updates at H.C. Wainwright
BioCardia said it will present CardiAMP regulatory progress, the ongoing CardiAMP HF II pivotal trial and Helix and Heart3D platform updates at the H.C. Wainwright conference.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.